PMA device
Medtronic CoreValve System
Medtronic, Inc. · Aortic Valve, Prosthesis, Percutaneously Delivered (NPT, Class III) · First FDA decision Jan 17, 2014, newest Dec 23, 2023Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
29
Naming "Medtronic CoreValve"
MAUDE reports
5
Brand "Medtronic CoreValve", since 2015
PubMed studies
380
Mentioning "Medtronic CoreValve"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic CoreValve System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
- Medtronic CoreValve System, Medtronic CoreValve Evolut R System, Medtronic CoreValve Evolut PRO SystemPMA supplement
P130021-S151 · Decided Dec 23, 2023 · 23 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Medtronic CoreValve System / Medtronic CoreValve Evolut R System/ Medtronic CoreValve Evolut PRO SystemPMA supplement
P130021-S041 · Decided Apr 6, 2018 · 245 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Medtronic CoreValve SystemPMA supplement
P130021-S034 · Decided May 9, 2017 · 61 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
3 more FDA decisions with a free account
Older decisions: P130021-S010, P130021-S004, P130021-S002, P130021
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430RUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430NUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR) for Aortic Regurgitation (AR)National analysisUnder reviewCAG-00430R3Updated Sep 14, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430R2Updated Sep 10, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National determinationOn the books20.32Updated Aug 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Medtronic CoreValve", any status and sponsor, newest update first.
- Evolut PRO China Clinical StudyActive, not recruiting
Medtronic CardiovascularPublic (MDT)
NCT04982588 · 52 participants · Start Jul 17, 2021 · Primary completion Mar 17, 2023
Device: Medtronic CoreValve™ Evolut™ PRO System · For: Severe, Symptomatic Aortic Stenosis
Sites: Beijing, China; Chengdu, China; Hangzhou, China · 4 sites in all
- Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk PatientsPivotal-lookingActive, not recruiting
Medtronic CardiovascularPublic (MDT)
NCT02701283 · 2,223 participants · Start Mar 2016 · Primary completion Apr 2021
Device: Medtronic Transcatheter Aortic Valve Replacement Systems; Surgical Aortic Valve Replacement (SAVR) · For: Aortic Valve Stenosis
Sites: Phoenix, Arizona; La Jolla, California; Los Angeles, California · 87 sites in all
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve ReplacementPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT03735667 · 1,948 participants · Start Jun 10, 2019 · Primary completion Jun 14, 2024
Device: ACURATE neo2™ Transfemoral TAVR System; Medtronic CoreValve TAVR System and 2 more · For: Aortic Stenosis
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 75 sites in all
26 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medtronic CoreValve", and for the whole product code for context.
This brand
5 reports: 1 malfunction, 4 injury, 0 death
Whole product code NPT
77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death
Newest reports for this brand
MW5163840 · Received Dec 26, 2024 · Event dated Dec 12, 2024
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Patient problem as coded: Aortic Valve Insufficiency/ Regurgitation
MW5163973 · Received Dec 26, 2024 · Event dated Dec 12, 2024
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Patient problem as coded: Aortic Valve Insufficiency/ Regurgitation
MW5162764 · Received Nov 20, 2024 · Event dated Nov 13, 2024
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Patient problem as coded: Tricuspid Valve Insufficiency/ Regurgitation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Medtronic Heart Valves Division
Z-0559-2021 · Started Oct 23, 2020
Reason given: Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).
Cause as FDA categorized it: Labeling design · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Medtronic Heart Valves Division
Z-0560-2021 · Started Oct 23, 2020
Reason given: Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).
Cause as FDA categorized it: Labeling design · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Medtronic Heart Valves Division
Z-0561-2021 · Started Oct 23, 2020
Reason given: Potential for Transcatheter Aortic Valve (TAV) leaflet damage when performing a post-implant balloon dilatation (PID).
Cause as FDA categorized it: Labeling design · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Medtronic CoreValve"[tiab]. The summary above synthesizes these.
- Transcatheter Aortic Valve Implantation.
Malaisrie SC, Iddriss A, Flaherty JD, et al. · Curr Atheroscler Rep · 2016Review
- Medtronic CoreValve Evolut valve.
Sinning JM, Werner N, Nickenig G, et al. · EuroIntervention · 2012Case Reports
- Medtronic CoreValve: Achieving Optimal Outcomes.
Stathogiannis K, Synetos A, Toutouzas K, et al. · Hellenic J Cardiol · 2015Review
- Cost-effectiveness analysis of TAVR.
Reardon MJ · Methodist Debakey Cardiovasc J · 2012Review
- The Lotus Valve System: an In-depth Review of the Technology.
Seigerman ME, Nathan A, Anwaruddin S · Curr Cardiol Rep · 2019Review
- Direct aortic transcatheter aortic valve implantation.
Karaçağlar E, Akgün AN, Aydnalp A, et al. · Turk Kardiyol Dern Ars · 2021Case Reports
- Subclinical Leaflet Thrombosis in Supra-annular Transcatheter Aortic Valves: the Role of Leaflet Design.
Qiu D, Azadani AN · J Cardiovasc Transl Res · 2023Research Support, Non-U.S. Gov't
- Medtronic CoreValve Evolut R with EnVeo R.
Sinning JM, Werner N, Nickenig G, et al. · EuroIntervention · 2013Research Support, Non-U.S. Gov't
- Multimodality noninvasive imaging for transcatheter aortic valve implantation: a primer.
Little SH, Shah DJ, Mahmarian JJ · Methodist Debakey Cardiovasc J · 2012Review
- Clinical studies assessing transcatheter aortic valve replacement.
Raheem S, Popma JJ · Methodist Debakey Cardiovasc J · 2012Research Support, Non-U.S. Gov't, Review
- Assessment of Prosthetic Valve Function After TAVR.
Pislaru SV, Nkomo VT, Sandhu GS · JACC Cardiovasc Imaging · 2016Review, Video-Audio Media
- Expansion of Medtronic-Corevalve: how much is enough?
Lemos PA · Catheter Cardiovasc Interv · 2010Editorial, Comment
Other devices of this type
Also filed under product code NPT.
- Sapien 3 Transcatheter Heart Valve and AccessoriesEdwards Lifesciences, LLC · PMA 2025
- Medtronic CoreValve Evolut R SystemMedtronic, Inc. · PMA 2022
- Edwards SAPIEN XT Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2020
- Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2026
- Edwards Sapien Transcatheter Heart Valve and Transfemoral and Transapical AccessoriesEdwards Lifesciences, LLC · PMA 2013
- Navitor Transcatheter Aortic Valve Implantation SystemAbbott Medical · PMA 2026
- Trilogy Transcatheter Heart Valve SystemJenaValve Technology, Inc. · PMA 2026
- LOTUS Edge Valve SystemBoston Scientific Corporation · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.